NattoPharma Names Vladimir Badmaev Head of R&D, Product Development
May 16, 2012, Oslo, Norway. The Board of publicly-traded company NattoPharma ASA, announces today that Vladimir Badmaev MD, PhD has accepted the appointment as Head of Research and Development at NattoPharma. Dr. Badmaev will lead NattoPharma’s research and development program to support its premium brand of vitamin K2, MenaQ7®, and also head the development of a line of biotechnology products based on fermentation technologies and a solvent-free green technology to broaden the food, nutraceutical and pharmaceutical applications of NattoPharma products.
“Dr. Badmaev is a much welcome addition to the NattoPharma team,” stated NattoPharma CEO Frode Bohan. “He has pioneered many leading ingredients in the natural products industry in his career, and his proven record of guiding product development will surely help us grow our Vitamin K2 franchise, as well as creating additional product offerings as we expand our biotechnology base.”
Dr. Badmaev received his MD and PhD (Immunopharmacology) in Bialystok, Poland and training in clinical and anatomical pathology at Kings County Hospital and Downstate Medical Center, New York (1982-1985). He is the author/coauthor of over 70 scientific and popular scientific articles, 13 books, 13 US and International patents and 9 successful IND applications with the FDA, several self-affirmed GRAS documents and NDI applications.
Prior to appointment with NattoPharma Dr. Badmaev has successfully served as a VP and Medical and Scientific Director with Sabinsa Inc. and PLThomas Inc. respectively, assisting those companies in building pre-clinical and clinical research on the innovative standardized food supplements. Recently, in a joint venture with a group of international investors he established American Medical Holdings, Inc., dedicated to developing natural and synthetic pharmaceuticals which he terms “Interactive nutrients.”
Dr. Badmaev is the 2004 recipient of the New Jersey R&D Council Thomas Alva Edison Award for ForsLean®, an ingredient promoting Lean Body Mass. He is the 2005 recipient of the Award for Bioperine® in promoting nutrient bioavailability and the 2009 recipient of Thomas Alva Edison Award for composition of Garcitrin ® natural and synthetic HCA for body weight management. Dr. Badmaev participated in the following Medical/Scientific Societies: International Society of Immunopharmacology (1982), American Association of Clinical Pathologists (1983), American Medical Association (1984), Research and Development Council of New Jersey (1996).
About NattoPharma
NattoPharma, Norway is the exclusive international supplier of MenaQ7, the natural vitamin K2. NattoPharma has entered into a multi-year research and development program to substantiate and discover the health benefits of natural vitamin K2 for applications in the exciting marketplace for functional food and health food supplements.
For more information, please visit www.nattopharma.com
About MenaQ7
MenaQ7 provides natural vitamin K2 as a fermentation extract whereby vitamin K2 is manufactured using bascillus subtilis natto. This process has the capacity of producing the highly pure and bio-available form of vitamin K2, menaquinone-7 (MK-7). MenaQ7 is the best documented, commercially available natural vitamin K2 with guaranteed actives and stability, clinical substantiation and international patents granted and pending.
For more information on the health benefits of MenaQ7, please visit www.menaq7.com
For more information, please contact:
Bertil Andersson
Chief Operations Officer (COO)
Mobile phone: +47 900 91 910
E-mail: bertil@nattopharma.com